Generic Name for Prolensa
The generic name for Prolensa is bromfenac.
Prolensa is specifically formulated as bromfenac ophthalmic solution 0.07%, which contains bromfenac sodium sesquihydrate (0.805 mg/mL, equivalent to 0.7 mg/mL bromfenac free acid) 1.
Key Details
Chemical Classification:
- Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for topical ophthalmic use
- Chemical name: sodium [2-amino-3-(4-bromobenzoyl) phenyl] acetate sesquihydrate
- Molecular formula: C₁₅H₁₁BrNNaO₃• 1½H₂O 1
Clinical Indication: Bromfenac ophthalmic solution is FDA-approved for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery 1.
Formulation Specifics:
- The solution has a pH of 7.8 and osmolality of approximately 300 mOsmol/kg
- Contains benzalkonium chloride 0.005% as preservative
- Administered once daily beginning 1 day prior to surgery, continuing through 14 days post-surgery 1
Important Note: While "bromfenac" is the generic drug name, when prescribing or dispensing, the complete designation should specify the concentration (0.07%) and formulation (ophthalmic solution) to ensure proper medication selection, as bromfenac is available in different concentrations for ophthalmic use.